
| Three Months | Six Months | |||||||||||||
| (unaudited) | (unaudited) | |||||||||||||
| Margin management | (2.6) | % | (2.9) | % | ||||||||||
| Consumption/other | (2.4) | (2.6) | ||||||||||||
| Griddle recall service impacts | (1.2) | (1.8) | ||||||||||||
| Volume/mix | (6.2) | % | (7.3) | % | ||||||||||
| Business acquisition | 4.5 | 4.6 | ||||||||||||
| Pricing | 4.2 | 2.6 | ||||||||||||
| Business exit | (1.0) | (0.7) | ||||||||||||
| Product recall returns | (0.2) | (0.3) | ||||||||||||
| Foreign currency | (0.1) | (0.1) | ||||||||||||
| Total change in net sales | 1.2 | % | (1.2) | % | ||||||||||
| Product recall returns/other | 0.2 | 0.3 | ||||||||||||
Total change in adjusted net sales(1) | 1.4 | % | (0.9) | % | ||||||||||
| The net sales increase of 1.2% was primarily due to the acquisition of the private brand tea business, favorable pricing to recover commodity inflation, and distribution gains. This was partially offset by volume/mix related to planned margin management actions, broader macroeconomic consumption trends, service impacts related to the voluntary recall of frozen griddle products, and the RTD business exit. | ||
| Gross Profit — Gross profit as a percentage of net sales was 17.4% in the second quarter of 2025, compared to 16.3% in the second quarter of 2024, an increase of 1.1 percentage points. The increase is primarily due to $13.1 million of insurance recoveries related to voluntary product recalls received during the second quarter of 2025, favorable margin from the Harris Tea acquisition and supply chain savings initiatives. This was partially offset by commodity cost inflation and unfavorable fixed cost absorption due to declining consumption trends. | ||
| Total Operating Expenses — Total operating expenses were $111.9 million in the second quarter of 2025 compared to $132.3 million in the second quarter of 2024, a decrease of $20.4 million. The decrease in expense is primarily due to a non-cash impairment charge recorded in the second quarter of 2024 of $19.3 million related to the Ready-to-drink beverages asset group, as well as cost reduction activities in 2025. | ||
| Total Other Expense — Total other expense was $32.9 million in the second quarter of 2025 compared to $16.9 million in the second quarter of 2024, an increase in expense of $16.0 million. The increase was due to a $16.2 million unfavorable change in non-cash mark-to-market impacts from hedging activities, driven by commodity contracts, primarily coffee, and interest rate swaps. Additionally, the Company had an increase of $6.6 million in interest expense primarily due to an increase in borrowings on our Revolving Credit Facility. This was partially offset by a favorable currency exchange rate impact of $6.2 million between the U.S. and Canada. | ||
| Income Taxes — Income taxes were recognized at an effective rate of 48.2% in the second quarter of 2025 compared to 20.1% recognized in the second quarter of 2024. The change in the Company’s effective tax rate is primarily driven by changes in the amounts of executive compensation that is not deductible for tax purposes and the estimated amount of annual pre-tax earnings. | ||
Net Loss and Adjusted EBITDA — Net loss for the second quarter of 2025 was $2.9 million, compared to $16.7 million for the same period of the previous year. Adjusted EBITDA1 was $73.3 million in the second quarter of 2025, compared to $70.6 million in the second quarter of 2024, an increase of $2.7 million. The increase in Adjusted EBITDA is primarily due to the supply chain savings initiatives, the accretive impact of the Harris Tea acquisition, and cost reduction activities. This was offset by commodity cost inflation and unfavorable fixed cost absorption due to declining consumption trends. | ||
Net Cash Used In Operating Activities — Net cash used in operating activities was $100.7 million in the first six months of 2025 compared to $71.8 million in the first six months of 2024, an increase in cash used of $28.9 million, which was primarily attributable to a decrease in cash flows from the Receivables Sales Program. This was partially offset by higher cash earnings reflecting the Company's pricing actions to recover commodity inflation. | ||
| June 30, 2025 | December 31, 2024 | |||||||||||||
| Assets | ||||||||||||||
| Current assets: | ||||||||||||||
| Cash and cash equivalents | $ | 17.1 | $ | 289.6 | ||||||||||
| Receivables, net | 212.0 | 146.8 | ||||||||||||
| Inventories | 634.8 | 539.3 | ||||||||||||
| Prepaid expenses and other current assets | 44.2 | 34.0 | ||||||||||||
| Total current assets | 908.1 | 1,009.7 | ||||||||||||
| Property, plant, and equipment, net | 758.5 | 748.6 | ||||||||||||
| Operating lease right-of-use assets | 183.8 | 154.4 | ||||||||||||
| Goodwill | 1,892.1 | 1,819.3 | ||||||||||||
| Intangible assets, net | 266.8 | 212.9 | ||||||||||||
| Other assets, net | 34.8 | 35.1 | ||||||||||||
| Total assets | $ | 4,044.1 | $ | 3,980.0 | ||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||
| Current liabilities: | ||||||||||||||
| Accounts payable | $ | 534.5 | $ | 602.5 | ||||||||||
| Accrued expenses | 179.9 | 141.3 | ||||||||||||
| Current portion of long-term debt | 5.8 | 1.1 | ||||||||||||
| Total current liabilities | 720.2 | 744.9 | ||||||||||||
| Long-term debt | 1,496.7 | 1,401.3 | ||||||||||||
| Operating lease liabilities | 144.9 | 125.4 | ||||||||||||
| Deferred income taxes | 106.3 | 105.8 | ||||||||||||
| Other long-term liabilities | 50.9 | 53.7 | ||||||||||||
| Total liabilities | 2,519.0 | 2,431.1 | ||||||||||||
| Commitments and contingencies | ||||||||||||||
| Stockholders' equity: | ||||||||||||||
Preferred stock, par value $0.01 per share, 10.0 shares authorized, none issued | — | — | ||||||||||||
| Common stock, par value $0.01 per share, 90.0 shares authorized, 50.5 and 50.2 shares outstanding as of June 30, 2025 and December 31, 2024, respectively | 0.6 | 0.6 | ||||||||||||
| Treasury stock | (385.4) | (385.4) | ||||||||||||
| Additional paid-in capital | 2,244.7 | 2,238.4 | ||||||||||||
| Accumulated deficit | (256.7) | (222.0) | ||||||||||||
| Accumulated other comprehensive loss | (78.1) | (82.7) | ||||||||||||
| Total stockholders' equity | 1,525.1 | 1,548.9 | ||||||||||||
| Total liabilities and stockholders' equity | $ | 4,044.1 | $ | 3,980.0 | ||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| Net sales | $ | 798.0 | $ | 788.5 | $ | 1,590.0 | $ | 1,609.2 | ||||||||||||||||||
| Cost of sales | 658.8 | 660.2 | 1,335.6 | 1,368.9 | ||||||||||||||||||||||
| Gross profit | 139.2 | 128.3 | 254.4 | 240.3 | ||||||||||||||||||||||
| Operating expenses: | ||||||||||||||||||||||||||
| Selling and distribution | 35.0 | 35.5 | 71.4 | 78.4 | ||||||||||||||||||||||
| General and administrative | 51.3 | 54.2 | 107.0 | 110.0 | ||||||||||||||||||||||
| Amortization expense | 13.2 | 12.1 | 26.3 | 24.2 | ||||||||||||||||||||||
| Asset impairment | — | 19.3 | — | 19.3 | ||||||||||||||||||||||
| Other operating expense, net | 12.4 | 11.2 | 27.9 | 17.6 | ||||||||||||||||||||||
| Total operating expenses | 111.9 | 132.3 | 232.6 | 249.5 | ||||||||||||||||||||||
| Operating income (loss) | 27.3 | (4.0) | 21.8 | (9.2) | ||||||||||||||||||||||
| Other expense: | ||||||||||||||||||||||||||
| Interest expense | 22.2 | 15.6 | 41.5 | 31.2 | ||||||||||||||||||||||
| Interest income | (0.2) | (0.1) | (3.0) | (4.1) | ||||||||||||||||||||||
| Loss on extinguishment of debt | — | — | 2.6 | — | ||||||||||||||||||||||
| (Gain) loss on foreign currency exchange | (4.7) | 1.5 | (5.0) | 4.9 | ||||||||||||||||||||||
| Other expense (income), net | 15.6 | (0.1) | 34.9 | (5.0) | ||||||||||||||||||||||
| Total other expense | 32.9 | 16.9 | 71.0 | 27.0 | ||||||||||||||||||||||
| Loss before income taxes | (5.6) | (20.9) | (49.2) | (36.2) | ||||||||||||||||||||||
| Income tax benefit | (2.7) | (4.2) | (14.5) | (7.8) | ||||||||||||||||||||||
| Net loss | $ | (2.9) | $ | (16.7) | $ | (34.7) | $ | (28.4) | ||||||||||||||||||
| Earnings (loss) per common share: | ||||||||||||||||||||||||||
| Basic | $ | (0.06) | $ | (0.32) | $ | (0.69) | $ | (0.54) | ||||||||||||||||||
| Diluted | (0.06) | (0.32) | (0.69) | (0.54) | ||||||||||||||||||||||
| Weighted average common shares: | ||||||||||||||||||||||||||
| Basic | 50.5 | 52.3 | 50.5 | 53.0 | ||||||||||||||||||||||
| Diluted | 50.5 | 52.3 | 50.5 | 53.0 | ||||||||||||||||||||||
| Six Months Ended June 30, | ||||||||||||||
| 2025 | 2024 | |||||||||||||
| Cash flows from operating activities: | ||||||||||||||
| Net loss | $ | (34.7) | $ | (28.4) | ||||||||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||||||||
| Depreciation and amortization | 83.5 | 72.8 | ||||||||||||
| Asset impairment | — | 19.3 | ||||||||||||
| Stock-based compensation | 10.4 | 11.0 | ||||||||||||
| Loss on extinguishment of debt | 2.6 | — | ||||||||||||
| Unrealized loss (gain) on derivative contracts | 31.7 | (8.5) | ||||||||||||
| Other, net | (6.1) | 2.7 | ||||||||||||
| Changes in operating assets and liabilities, net of acquisitions: | ||||||||||||||
| Receivables | (50.6) | (10.5) | ||||||||||||
| Inventories | (50.5) | (60.6) | ||||||||||||
| Prepaid expenses and other assets | (25.3) | (6.9) | ||||||||||||
| Accounts payable | (75.6) | (47.1) | ||||||||||||
| Accrued expenses and other liabilities | 13.9 | (15.6) | ||||||||||||
| Net cash used in operating activities | (100.7) | (71.8) | ||||||||||||
| Cash flows from investing activities: | ||||||||||||||
| Capital expenditures | (54.0) | (51.1) | ||||||||||||
| Proceeds from sales of fixed assets | 4.8 | 1.4 | ||||||||||||
| Acquisition, net of cash acquired | (209.3) | — | ||||||||||||
| Net cash used in investing activities | (258.5) | (49.7) | ||||||||||||
| Cash flows from financing activities: | ||||||||||||||
| Borrowings under Revolving Credit Facility | 1,409.5 | 9.5 | ||||||||||||
| Payments under Revolving Credit Facility | (1,304.5) | (9.5) | ||||||||||||
| Payments on financing lease obligations | (1.2) | (0.3) | ||||||||||||
| Payment of deferred financing costs | (3.7) | — | ||||||||||||
| Payments on Term Loans | (906.0) | — | ||||||||||||
| Proceeds from refinanced Term Loans | 899.2 | — | ||||||||||||
| Repurchases of common stock | — | (88.7) | ||||||||||||
| Payments related to stock-based award activities | (4.1) | (3.9) | ||||||||||||
| Net cash provided by (used in) financing activities | 89.2 | (92.9) | ||||||||||||
| Effect of exchange rate changes on cash and cash equivalents | (2.5) | (0.1) | ||||||||||||
| Net decrease in cash and cash equivalents | (272.5) | (214.5) | ||||||||||||
| Cash and cash equivalents, beginning of period | 289.6 | 320.3 | ||||||||||||
| Cash and cash equivalents, end of period | $ | 17.1 | $ | 105.8 | ||||||||||
| Six Months Ended June 30, | ||||||||||||||
| 2025 | 2024 | |||||||||||||
| Supplemental cash flow disclosures: | ||||||||||||||
| Interest paid | $ | 46.1 | $ | 42.5 | ||||||||||
| Net income taxes paid | 16.7 | 6.6 | ||||||||||||
| Non-cash investing and financing activities: | ||||||||||||||
| Capital expenditures incurred but not yet paid | 14.4 | 22.3 | ||||||||||||
| Right-of-use assets obtained in exchange for lease obligations | 44.9 | 0.3 | ||||||||||||
| Preliminary purchase price adjustment for private brand tea business acquisition | 2.0 | — | ||||||||||||
| Accrued deferred financing costs | 0.2 | — | ||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| Net loss (GAAP) | $ | (2.9) | $ | (16.7) | $ | (34.7) | $ | (28.4) | ||||||||||||||||||
| Interest expense | 22.2 | 15.6 | 41.5 | 31.2 | ||||||||||||||||||||||
| Interest income | (0.2) | (0.1) | (3.0) | (4.1) | ||||||||||||||||||||||
| Income tax benefit | (2.7) | (4.2) | (14.5) | (7.8) | ||||||||||||||||||||||
| Depreciation and amortization | 42.1 | 36.2 | 83.5 | 72.8 | ||||||||||||||||||||||
| EBITDA (Non-GAAP) | 58.5 | 30.8 | 72.8 | 63.7 | ||||||||||||||||||||||
Mark-to-market adjustments(1) | 14.7 | (1.5) | 31.7 | (8.5) | ||||||||||||||||||||||
Restructuring programs & other, excluding accelerated depreciation(2) | 12.7 | 11.5 | 28.1 | 18.2 | ||||||||||||||||||||||
Acquisition, integration, divestiture, and related costs(3) | 0.7 | 1.9 | 3.2 | 6.0 | ||||||||||||||||||||||
Foreign currency (gain) loss on re-measurement of intercompany notes(4) | (3.7) | 1.1 | (3.9) | 3.5 | ||||||||||||||||||||||
Product recalls and related (income) costs, including insurance recoveries(5) | (9.6) | 7.5 | (3.7) | 14.4 | ||||||||||||||||||||||
Loss on extinguishment of debt(6) | — | — | 2.6 | — | ||||||||||||||||||||||
Impairment(7) | — | 19.3 | — | 19.3 | ||||||||||||||||||||||
| Adjusted EBITDA (Non-GAAP) | $ | 73.3 | $ | 70.6 | $ | 130.8 | $ | 116.6 | ||||||||||||||||||
| % of net sales | ||||||||||||||||||||||||||
| Net loss margin | (0.4) | % | (2.1) | % | (2.2) | % | (1.8) | % | ||||||||||||||||||
| EBITDA margin | 7.3 | % | 3.9 | % | 4.6 | % | 4.0 | % | ||||||||||||||||||
| % of adjusted net sales | ||||||||||||||||||||||||||
| Adjusted EBITDA margin | 9.1 | % | 8.9 | % | 8.2 | % | 7.2 | % | ||||||||||||||||||
| (1) | The Company's derivative contracts are marked-to-market each period. The non-cash unrealized changes in fair value recognized in Other expense (income), net within the Condensed Consolidated Statements of Operations are treated as Non-GAAP adjustments. As the contracts are settled, realized gains and losses are recognized, and only the mark-to-market impacts are treated as Non-GAAP adjustments. | ||||
| (2) | The Company's restructuring and margin improvement activities are part of an enterprise-wide transformation to improve the long-term profitability of the Company. During the three and six months ended June 30, 2025, the Company recognized $2.9 million and $5.8 million, respectively, of accelerated depreciation within the Company's restructuring activities as depreciation expense. There was no accelerated depreciation recognized during the three and six months ended June 30, 2024. | ||||
| (3) | Acquisition, integration, divestiture, and related costs represents costs associated with completed and potential acquisitions, the related integration of the acquisitions, completed and potential divestitures, and gains or losses on the divestiture of a business. During the three and six months ended June 30, 2025, $0.5 million and $0.8 million were classified in General and administrative and $0.2 million and $0.5 million were classified in Net sales, respectively. Additionally, $1.9 million was classified in Cost of sales during the six months ended June 30, 2025. During the three and six months ended June 30, 2024, $1.7 million and $3.7 million were classified in General and administrative and $0.2 million and $2.1 million were classified in Cost of sales, respectively. Additionally, $0.2 million was classified in Other operating expense, net during the six months ended June 30, 2024. | ||||
| (4) | The Company has foreign currency denominated intercompany loans and incurred foreign currency gains/losses to re-measure the loans at quarter end. These amounts are non-cash and the loans are eliminated in consolidation. | ||||
| (5) | Griddle Recall and Related (Income) Costs, including Insurance Recoveries On October 18, 2024, the Company initiated a voluntary recall of certain frozen waffle products produced at its Brantford, Ontario, Canada facility, and on October 22, 2024, the Company expanded its voluntary recall to include all products manufactured at the Brantford facility that are still within their shelf-life. For the three and six months ended June 30, 2025, the Non-GAAP adjustments included an insurance recovery of $(10.0) million in each period and $3.4 million and $9.2 million for estimated product returns and claims, respectively. Broth Recall and Related (Income) Costs, including Insurance Recoveries On September 22, 2023, the Company initiated a voluntary recall of certain broth products produced at its Cambridge, Maryland facility and executed a turnaround plan to restore the facility operations. For the three and six months ended June 30, 2025, the Non-GAAP adjustments included an insurance recovery of $(3.1) million in each period and other costs of $0.1 million and $0.2 million, respectively. For the three and six months ended June 30, 2024, the Non-GAAP adjustments included non-cash plant shutdown charges of $4.5 million and $8.9 million, non-cash inventory write-offs of $0.3 million and $2.6 million, and other costs, including product returns and logistics, of $2.7 million and $2.9 million, respectively. | ||||
| (6) | During the first quarter of 2025, the Company incurred a loss on extinguishment of debt, which included a write off of deferred financing costs of $2.6 million in connection with the Credit Agreement refinancing. | ||||
| (7) | During the second quarter of 2024, the Company incurred $19.3 million of non-cash impairment charges related to property, plant, and equipment. The impairment is due to forecasted cash flow losses in the Ready-to-drink beverages business resulting in a decision to exit this business. | ||||
| Three Months Ended June 30, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Net sales | Cost of sales | Gross profit | Total operating expenses | Operating income | Total other expense | Income tax (benefit) expense | Net (loss) income | |||||||||||||||||||||||||||||||||||||||||||
| As reported (GAAP) | $ | 798.0 | $ | 658.8 | $ | 139.2 | $ | 111.9 | $ | 27.3 | $ | 32.9 | $ | (2.7) | $ | (2.9) | ||||||||||||||||||||||||||||||||||
| Adjustments: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Mark-to-market adjustments(1) | — | — | — | — | — | (14.7) | — | 14.7 | ||||||||||||||||||||||||||||||||||||||||||
Restructuring programs & other, including accelerated depreciation(2) | — | (2.9) | 2.9 | (12.7) | 15.6 | — | — | 15.6 | ||||||||||||||||||||||||||||||||||||||||||
Acquisition, integration, divestiture, and related costs(3) | 0.2 | — | 0.2 | (0.5) | 0.7 | — | — | 0.7 | ||||||||||||||||||||||||||||||||||||||||||
Foreign currency gain on re-measurement of intercompany notes(4) | — | — | — | — | — | 3.7 | — | (3.7) | ||||||||||||||||||||||||||||||||||||||||||
Product recalls and related (income) costs, including insurance recoveries(5) | 3.2 | 12.8 | (9.6) | — | (9.6) | — | — | (9.6) | ||||||||||||||||||||||||||||||||||||||||||
| Taxes on adjusting items | — | — | — | — | — | — | 6.0 | (6.0) | ||||||||||||||||||||||||||||||||||||||||||
| As adjusted (Non-GAAP) | $ | 801.4 | $ | 668.7 | $ | 132.7 | $ | 98.7 | $ | 34.0 | $ | 21.9 | $ | 3.3 | $ | 8.8 | ||||||||||||||||||||||||||||||||||
| As reported (% of net sales) | 17.4 | % | 14.0 | % | 3.4 | % | 4.1 | % | (0.3) | % | (0.4) | % | ||||||||||||||||||||||||||||||||||||||
| As adjusted (% of adjusted net sales) | 16.6 | % | 12.3 | % | 4.2 | % | 2.7 | % | 0.4 | % | 1.1 | % | ||||||||||||||||||||||||||||||||||||||
| Earnings (loss) per share: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted | $ | (0.06) | ||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted diluted | $ | 0.17 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Weighted average common shares: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted for net loss | 50.5 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted for adjusted net income | 50.6 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Three Months Ended June 30, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Net sales | Cost of sales | Gross profit | Total operating expenses | Operating (loss) income | Total other expense | Income tax (benefit) expense | Net (loss) income | |||||||||||||||||||||||||||||||||||||||||||
| As reported (GAAP) | $ | 788.5 | $ | 660.2 | $ | 128.3 | $ | 132.3 | $ | (4.0) | $ | 16.9 | $ | (4.2) | $ | (16.7) | ||||||||||||||||||||||||||||||||||
| Adjustments: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Mark-to-market adjustments(1) | — | — | — | — | — | 1.5 | — | (1.5) | ||||||||||||||||||||||||||||||||||||||||||
Restructuring programs & other(2) | — | — | — | (11.5) | 11.5 | — | — | 11.5 | ||||||||||||||||||||||||||||||||||||||||||
Acquisition, integration, divestiture, and related costs(3) | — | (0.2) | 0.2 | (1.7) | 1.9 | — | — | 1.9 | ||||||||||||||||||||||||||||||||||||||||||
Foreign currency loss on re-measurement of intercompany notes(4) | — | — | — | — | — | (1.1) | — | 1.1 | ||||||||||||||||||||||||||||||||||||||||||
Product recalls and related costs(5) | 1.4 | (6.1) | 7.5 | — | 7.5 | — | — | 7.5 | ||||||||||||||||||||||||||||||||||||||||||
Impairment(7) | — | — | — | (19.3) | 19.3 | — | — | 19.3 | ||||||||||||||||||||||||||||||||||||||||||
| Taxes on adjusting items | — | — | — | — | — | — | 8.1 | (8.1) | ||||||||||||||||||||||||||||||||||||||||||
| As adjusted (Non-GAAP) | $ | 789.9 | $ | 653.9 | $ | 136.0 | $ | 99.8 | $ | 36.2 | $ | 17.3 | $ | 3.9 | $ | 15.0 | ||||||||||||||||||||||||||||||||||
| As reported (% of net sales) | 16.3 | % | 16.8 | % | (0.5) | % | 2.1 | % | (0.5) | % | (2.1) | % | ||||||||||||||||||||||||||||||||||||||
| As adjusted (% of adjusted net sales) | 17.2 | % | 12.6 | % | 4.6 | % | 2.2 | % | 0.5 | % | 1.9 | % | ||||||||||||||||||||||||||||||||||||||
| Earnings (loss) per share | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted | $ | (0.32) | ||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted diluted | $ | 0.29 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Weighted average common shares: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted for net loss | 52.3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted for adjusted net income | 52.5 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Six Months Ended June 30, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Net sales | Cost of sales | Gross profit | Total operating expenses | Operating income | Total other expense | Income tax (benefit) expense | Net (loss) income | |||||||||||||||||||||||||||||||||||||||||||
| As reported (GAAP) | $ | 1,590.0 | $ | 1,335.6 | $ | 254.4 | $ | 232.6 | $ | 21.8 | $ | 71.0 | $ | (14.5) | $ | (34.7) | ||||||||||||||||||||||||||||||||||
| Adjustments: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Mark-to-market adjustments(1) | — | — | — | — | — | (31.7) | — | 31.7 | ||||||||||||||||||||||||||||||||||||||||||
Restructuring programs & other, including accelerated depreciation(2) | — | (5.7) | 5.7 | (28.2) | 33.9 | — | — | 33.9 | ||||||||||||||||||||||||||||||||||||||||||
Acquisition, integration, divestiture, and related costs(3) | 0.5 | (1.9) | 2.4 | (0.8) | 3.2 | — | — | 3.2 | ||||||||||||||||||||||||||||||||||||||||||
Foreign currency gain on re-measurement of intercompany notes(4) | — | — | — | — | — | 3.9 | — | (3.9) | ||||||||||||||||||||||||||||||||||||||||||
Product recalls and related (income) costs, including insurance recoveries(5) | 6.9 | 12.9 | (6.0) | (2.3) | (3.7) | — | — | (3.7) | ||||||||||||||||||||||||||||||||||||||||||
Loss on extinguishment of debt(6) | — | — | — | — | — | (2.6) | — | 2.6 | ||||||||||||||||||||||||||||||||||||||||||
| Taxes on adjusting items | — | — | — | — | — | — | 18.8 | (18.8) | ||||||||||||||||||||||||||||||||||||||||||
| As adjusted (Non-GAAP) | $ | 1,597.4 | $ | 1,340.9 | $ | 256.5 | $ | 201.3 | $ | 55.2 | $ | 40.6 | $ | 4.3 | $ | 10.3 | ||||||||||||||||||||||||||||||||||
| As reported (% of net sales) | 16.0 | % | 14.6 | % | 1.4 | % | 4.5 | % | (0.9) | % | (2.2) | % | ||||||||||||||||||||||||||||||||||||||
| As adjusted (% of adjusted net sales) | 16.1 | % | 12.6 | % | 3.5 | % | 2.5 | % | 0.3 | % | 0.6 | % | ||||||||||||||||||||||||||||||||||||||
| Earnings (loss) per share: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted | $ | (0.69) | ||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted diluted | $ | 0.20 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Weighted average common shares: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted for net loss | 50.5 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted for adjusted net income | 50.5 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Six Months Ended June 30, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Net sales | Cost of sales | Gross profit | Total operating expenses | Operating (loss) income | Total other expense | Income tax (benefit) expense | Net (loss) income | |||||||||||||||||||||||||||||||||||||||||||
| As reported (GAAP) | $ | 1,609.2 | $ | 1,368.9 | $ | 240.3 | $ | 249.5 | $ | (9.2) | $ | 27.0 | $ | (7.8) | $ | (28.4) | ||||||||||||||||||||||||||||||||||
| Adjustments: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Mark-to-market adjustments(1) | — | — | — | — | — | 8.5 | — | (8.5) | ||||||||||||||||||||||||||||||||||||||||||
Restructuring programs & other(2) | — | — | — | (18.2) | 18.2 | — | — | 18.2 | ||||||||||||||||||||||||||||||||||||||||||
Acquisition, integration, divestiture, and related costs(3) | — | (2.1) | 2.1 | (3.9) | 6.0 | — | — | 6.0 | ||||||||||||||||||||||||||||||||||||||||||
Foreign currency loss on re-measurement of intercompany notes(4) | — | — | — | — | — | (3.5) | — | 3.5 | ||||||||||||||||||||||||||||||||||||||||||
Product recalls and related costs(5) | 2.3 | (12.1) | 14.4 | — | 14.4 | — | — | 14.4 | ||||||||||||||||||||||||||||||||||||||||||
Impairment(7) | — | — | — | (19.3) | 19.3 | — | — | 19.3 | ||||||||||||||||||||||||||||||||||||||||||
| Taxes on adjusting items | — | — | — | — | — | — | 11.3 | (11.3) | ||||||||||||||||||||||||||||||||||||||||||
| As adjusted (Non-GAAP) | $ | 1,611.5 | $ | 1,354.7 | $ | 256.8 | $ | 208.1 | $ | 48.7 | $ | 32.0 | $ | 3.5 | $ | 13.2 | ||||||||||||||||||||||||||||||||||
| As reported (% of net sales) | 14.9 | % | 15.5 | % | (0.6) | % | 1.7 | % | (0.5) | % | (1.8) | % | ||||||||||||||||||||||||||||||||||||||
| As adjusted (% of adjusted net sales) | 15.9 | % | 12.9 | % | 3.0 | % | 2.0 | % | 0.2 | % | 0.8 | % | ||||||||||||||||||||||||||||||||||||||
| Earnings per share: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted | $ | (0.54) | ||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted diluted | $ | 0.25 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Weighted average common shares: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted for net loss | 53.0 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted for adjusted net income | 53.4 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Six Months Ended June 30, | ||||||||||||||
| 2025 | 2024 | |||||||||||||
| Cash flow used in operating activities (GAAP) | $ | (100.7) | $ | (71.8) | ||||||||||
| Capital expenditures | (54.0) | (51.1) | ||||||||||||
| Proceeds from sales of fixed assets | 4.8 | 1.4 | ||||||||||||
| Free cash flow (Non-GAAP) | $ | (149.9) | $ | (121.5) | ||||||||||